Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Charles River Laboratories International, Inc.    CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(CRL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Number of employees : 17 100 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Discovery and Safety Assessment1,31758.1%1,61961.8% +22.94%
Research Models & Services519.6822.9%537.0920.5% +3.35%
Manufacturing Support429.5619%465.1417.7% +8.28%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States1,26855.9%1,47156.1% +16.05%
Europe643.9628.4%726.4227.7% +12.81%
Canada206.389.1%271.9910.4% +31.79%
Asia Pacific142.506.3%146.225.6% +2.61%
Other5.640.2%5.500.2% -2.46%
Managers and Directors
NameAgeSinceTitle
James Foster692018Chairman, President & Chief Executive Officer
David Smith552017Chief Financial Officer & Executive Vice President
Shanna L. Cotti-Osmanski-2006Chief Information Officer
George E. Massaro72-Independent Director
George M. Milne, Dr.76-Lead Independent Director
Stephen D. Chubb76-Independent Director
C. Richard Reese74-Independent Director
Deborah Turner Kochevar, Dr.63-Independent Director
Robert J. Bertolini58-Independent Director
Richard F. Wallman69-Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,888,626 49,009,415 98.2% 146,000 0.3% 98.2%
Shareholders
NameEquities%
Capital Research & Management Co. (World Investors) 5,555,000 11.2%
The Vanguard Group, Inc. 4,839,699 9.73%
Capital Research & Management Co. 4,355,000 8.76%
JANA Partners LLC 4,109,113 8.26%
BAMCO, Inc. 1,859,611 3.74%
John W. Bristol & Co., Inc. (New York) 1,824,059 3.67%
Fidelity Management & Research Co. LLC 1,768,223 3.55%
Viking Global Investors LP 1,732,229 3.48%
BlackRock Fund Advisors 1,548,015 3.11%
Oppenheimer Capital 1,408,500 2.83%
Company contact information
Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington, MA 01887

Phone : +1.781.222.6000
Fax : +1.978.988.5665
Web : http://www.criver.com